Not exact matches
The family of the woman whose
cells have helped advance a great deal of biological research has agreed to a case - by - case release of her
genomic data
They elaborate on several focus areas described by the White House earlier: preventive vaccines, early detection, single cancer
cell genomics, immunotherapy, pediatric cancer, and
data sharing.
A strategic focus is to continue to develop computational tools (such as KinomeXplorer, NetworKIN, and NetPhorest) and to deploy these on genome - scale quantitative
data obtained by, for example, mass spectrometry,
genomic, and phenotypic screens to understand the principles of how spatio and temporal assembly of mammalian signaling networks transmit and process information at a systems level in order to alter
cell behavior.
Genomic data from the HeLa
cell line are also being released with the final version of the paper as a result of discussions between leaders of the National Institutes of Health (NIH) and relatives of Henrietta Lacks, from whose cervical tumor the original HeLa
cell line was derived prior to her death in 1951.
Importantly, all researchers who use or generate full
genomic data from HeLa
cells will now be asked to include in their publications an acknowledgement and expression of gratitude to the Lacks family for their contributions.
«We have taken the
data offline until the question has been resolved of whether the family consents to the public availability of
genomic information on the
cell line,» writes an EMBL spokesperson in an e-mail to ScienceInsider.
The study compared multiple techniques — or assays — used to analyze
genomic data from a glioblastoma patient's tumor
cells and normal healthy
cells.
Applying these methods to prostate cancer
cell lines, the researchers found that accurate predictions of drug sensitivity could be achieved using either
genomics data or phosphoproteomics
data alone.
Integration of our
genomics, genetics,
cell biological and biochemical approaches, supported with computational
data mining, provides insight into the multi-layered gene expression networks and of regulatory strategies orchestrating biological processes.
Caribou Biosciences has generated hundreds of thousands of
data points from engineering many thousands of
genomic sites across several different
cell types.
The new dependency
data complement the Dependency Map team's ongoing efforts to use functional
genomic technologies like CRISPR and RNA interference (RNAi) to locate vulnerabilities that arise within cancer
cells as they compensate for the loss of critical genes due to mutations or expression changes.
Improving human health by enabling safer, more effective
cell and gene medicines through proprietary
genomics, bioinformatics and intelligent
data driven design
Conventional
genomic analysis from a bulk sample of
cells produces
data that average the differences among the individual
cells within the sample.
Research Focus: I am highly trained in producing and purifying monoclonal antibodies from Hybridoma
cells, performing ELISA assays, preparing primary
cells from organs and analyzing
cell populations using FlowJo Cytometry
data analysis software, isolating
genomic DNA from animal tissues, maintaining and screening numerous transgenic and knock out mice lines by PCR and FACS.
Cell biology has continued to expand ever since, extending its impact on clinical medicine and pharmacology while drawing on new technologies in bioengineering, high - resolution imaging, massive
data handling, and
genomic sequencing.
Researchers at the Wellcome Sanger Institute and Newcastle University have collected
genomic data from over 250 thousand
cells from a range of donated developing human tissues including liver, skin, kidney and placenta.
The Cancer Genome Atlas is using
genomic, transcriptomic, and epigenomic measurements of cancer
cells, coupled with computational approaches and rich clinical
data, to understand the dysfunctions that underline the onset, progression, and spread of cancer.
Although the database described here was based on the gene expression profiling results of the FunGenES consortium, it can be easily adapted to incorporate available or future
genomics data obtained in ES
cells.
Specifically, we have generated clusters of transcripts that behave the same way under the entire spectrum of the sixty - seven experimental conditions; we have assembled genes in groups according to their time of expression during successive days of ES
cell differentiation; we have included expression profiles of specific gene classes such as transcription regulatory factors and Expressed Sequence Tags; transcripts have been arranged in «Expression Waves» and juxtaposed to genes with opposite or complementary expression patterns; we have designed search engines to display the expression profile of any transcript during ES
cell differentiation; gene expression
data have been organized in animated graphs of KEGG signaling and metabolic pathways; and finally, we have incorporated advanced functional annotations for individual genes or gene clusters of interest and links to microarray and
genomic resources.
We combine biochemical, structural, cellular and functional information using purified proteins, mutant and transgenic plants, yeast and chemical
genomic screening systems, transient gene expression assays, confocal microscopy and in silico
data analysis to compare ROP - centered kinase signaling during
cell polarity (in vitro pollen tubes), morphogenesis (whole plant) and pathogenesis (fungi - infected
cells).